乳腺癌改良根治术后大分割放疗后放射性淋巴细胞减少的纵向分析及预测因素:两项前瞻性试验的汇总队列研究
该汇总队列研究前瞻性评估了8家医院607例接受大分割改良根治术后放疗的乳腺癌患者,发现19.9%患者出现≥3级放射性淋巴细胞减少,外周淋巴细胞计数在放疗后1年开始恢复、2年超过放疗前水平;整合光子调强放疗较混合放疗与更低的淋巴细胞最低值显著相关。
要点
- 放疗期间19.9%患者出现≥3级放射性淋巴细胞减少,最低值0.75±0.33×10^9/L。
- 外周淋巴细胞计数放疗后1周开始恢复,1年达放疗前水平,2年超过放疗前水平。
- 整合光子调强放疗较混合放疗与更低的淋巴细胞最低值显著相关(P<.001)。
核心结论
- 乳腺癌患者放疗后存在持续性淋巴细胞减少,整合放疗增加放射性淋巴细胞减少风险并对恢复产生不良影响,应考虑合适的放疗技术以尽量减少放射性淋巴细胞减少。
研究设计与样本
- 汇总两项前瞻性试验,纳入8家医院607例接受大分割改良根治术后放疗的乳腺癌患者。
- 放疗技术包括整合光子调强技术(整合放疗)和光子照射锁骨上淋巴结联合电子照射胸壁和/或内乳淋巴结(混合放疗)。
- 外周淋巴细胞计数在放疗前、放疗期间每周、放疗后1周、2周、3个月、6个月及之后每6个月检测。
- 主要结局为放疗期间淋巴细胞最低值,采用单因素、多因素线性回归和倾向性评分匹配分析。
主要发现
- 放疗期间121例(19.9%)患者出现≥3级放射性淋巴细胞减少,最低值为0.75±0.33×10^9/L。
- 外周淋巴细胞计数放疗后1周开始恢复,放疗后1年达到放疗前水平,2年后高于放疗前水平。
- 多因素分析确定年轻年龄、低体重指数、放疗靶区涉及多个区域、整合放疗和放疗前低外周淋巴细胞计数为淋巴细胞最低值的独立危险因素(P<.005)。
- 整合放疗组在放疗期间和放疗后各时间点的外周淋巴细胞计数均低于混合放疗组(P<.05)。
- 倾向性评分匹配前后,调整放疗靶区和年龄后,整合放疗与更低的淋巴细胞最低值显著相关(P<.001)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiation-induced lymphopenia (RIL) correlates with poor prognoses in solid tumors. This study aimed to investigate the post-radiation therapy (RT) longitudinal lymphocyte changes and the impact of different RT techniques on RIL in breast cancer patients. METHODS AND MATERIALS: We prospectively assessed 607 breast cancer patients who received hypofractionated postmastectomy RT in 8 hospitals. Radiation therapy techniques included integrated photon-based intensity modulated technique (integrated RT) and a combination of photon irradiation of supraclavicular nodes and electron irradiation of the chest wall and/or the internal mammary node (hybrid RT). Peripheral lymphocyte counts (PLC) were determined before RT, weekly during RT, at 1 and 2 weeks, 3 and 6 months post-RT, and then every 6 months. The primary outcome was the nadir PLC during RT, for which associated factors were analyzed. Univariate, multivariable linear regression and propensity score matching analyses were performed to evaluate the effect of different RT techniques on nadir PLC. RESULTS: During RT, 121 (19.9%) patients had grade ≥3 RIL with a nadir PLC of 0.75 ± 0.33 × 109/L. The PLC started to recover at 1 week and reached pre-RT levels 1 year after RT and higher than pre-RT levels 2 years later. Multivariate analysis identified young age, low body mass index, radiation therapy targets involving multiple regions, integrated RT, and low pre-radiation therapy PLC as independent risk factors for nadir PLC (P < .005). The PLC at each time point during and after radiation therapy was lower in patients receiving integrated RT than in those receiving hybrid RT (P < .05). Before and after propensity score matching, integrated RT was significantly associated with lower nadir PLC after adjusting for radiation therapy targets and age (P < .001). CONCLUSIONS: Breast cancer patients had prolonged lymphopenia post-RT. Integrated RT increased the risk of RIL and adversely affected recovery. Therefore, an appropriate RT technique should be considered to minimize RIL.
引用
- Zhao XR, Fang H, Jing H, et al. Longitudinal Analyses and Predictive Factors of Radiation-Induced Lymphopenia After Postmastectomy Hypofractionated Radiation Therapy for Breast Cancer: A Pooled Cohort Study of 2 Prospective Trials. Adv Radiat Oncol. 2025. PMID: 40241739. doi:10.1016/j.adro.2025.101750
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。